首页> 外文期刊>Current Bioactive Compounds >The In Vitro and In Vivo Inhibitory Effect of Dehydroaltenusin: A Specific Inhibitor of Mammalian DNA Polymerase α
【24h】

The In Vitro and In Vivo Inhibitory Effect of Dehydroaltenusin: A Specific Inhibitor of Mammalian DNA Polymerase α

机译:脱氢altenusin的体外和体内抑制作用:哺乳动物DNA聚合酶α的特异性抑制剂。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In the screening of the selective inhibitors of eukaryotic DNA polymerases (pols), dehydroaltenusin was found to be an inhibitor of pol from a fungus (Alternaria tennuis). This compound inhibited only mammalian polα, and did not influence the activities of other replicative pols such as polsαs and Ƹ , but also showed no effect even on polαactivity from another vertebrate, fish, or from a plant species. Dehydroaltenusin also had no influence DNA metabolic enzymes tested. The inhibitory effect of dehydroaltenusin on mammalian polαwas dose-dependent with IC50 value of 0.5 ?M. This effect was 10-fold stronger than that of aphidicolin, a well-known potent eukaryotic polαinhibitor. The inhibitory mode of dehydroaltenusin for mammalian polαactivity was competitive with the DNA template-primer and noncompetitive with the dNTP substrate. We succeeded in chemically synthesizing dehydroaltenusin, and the compound inhibited the cell proliferation of human gastric cancer cell lines by arresting the cells at the S-phase, and preventing the incorporation of thymidine into the cells, indicating that it blocks in vivo DNA replication by inhibiting polα. This compound also induced cell apoptosis. Furthermore, we investigated in vivo anti-tumor effects on nude mice bearing solid tumors of the human cervical cancer cell line HeLa. Dehydroaltenusin was significantly effective in suppressing the growth of solid tumors, therefore, it was of interest as a candidate drug for anti-cancer treatment. These results suggested that dehydroaltenusin is a mammalian polα-specific inhibitor useful in both in vivo and in vitro experiments.
机译:在筛选真核DNA聚合酶(pols)的选择性抑制剂时,发现脱氢altenusin是真菌(Alternaria tennuis)的pol的抑制剂。该化合物仅抑制哺乳动物的polα,并且不影响其他复制性pols(例如polsαs和Ƹ)的活性,甚至对其他脊椎动物,鱼类或植物物种的polα活性也没有影响。脱氢altenusin也没有影响测试的DNA代谢酶。脱氢altenusin对哺乳动物polα的抑制作用呈剂量依赖性,IC50值为0.5?M。该作用比著名的强效真核polα抑制剂蚜虫二倍要强十倍。脱氢altenusin对哺乳动物polα活性的抑制方式与DNA模板引物竞争,而与dNTP底物竞争。我们成功地化学合成了脱氢altenusin,该化合物通过将细胞阻滞在S期并抑制胸苷掺入细胞来抑制人胃癌细胞系的细胞增殖,这表明它通过抑制抑制DNA的体内复制polα。该化合物还诱导细胞凋亡。此外,我们研究了对携带人宫颈癌HeLa实体瘤的裸鼠的体内抗肿瘤作用。脱氢altenusin在抑制实体瘤的生长方面非常有效,因此,它作为抗癌治疗的候选药物引起了人们的兴趣。这些结果表明,脱氢altenusin是可用于体内和体外实验的哺乳动物polα特异性抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号